6AYN
Structure of cetuximab with aminoheptanoic acid-linked N-(3-aminopropyl)-L-arginine meditope variant
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2012-05-01 |
Detector | RIGAKU RAXIS IV++ |
Wavelength(s) | 1.5418 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 64.480, 82.900, 212.000 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 33.121 - 2.480 |
R-factor | 0.174 |
Rwork | 0.172 |
R-free | 0.22170 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4gw1 |
RMSD bond length | 0.007 |
RMSD bond angle | 0.896 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX (1.12_2829) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 33.121 | 2.540 |
High resolution limit [Å] | 2.480 | 2.480 |
Rmerge | 0.066 | 0.296 |
Number of reflections | 40771 | 2714 |
<I/σ(I)> | 24.3 | 5.3 |
Completeness [%] | 99.0 | 91 |
Redundancy | 4.6 | 3.5 |
CC(1/2) | 0.998 | 0.921 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.1 M citrate pH 5, 1.6 M ammonium sulfate |